Recent News

559 News Items found
Mount Rushmore viewed through face-detection software.
Taking a cue from smartphone technology, scientists are using face-recognition algorithms to improve RNA interference.
Grey T lymphocytes
Finding
A team at MSK uncovered how TRX518, a new immunotherapy drug in early development, works in the body.
Wearable device on woman’s arm with labels indicating beams going into nanotubes and coming back out for analysis.
In the Lab
Learn how tiny sensors made of nanotubes could serve as implantable devices that offer a noninvasive way to monitor cancer and its treatments.
Adrienne Boire at the lab bench
In the Lab
Research is providing new clues about how cancer spreads to spinal fluid, a condition called leptomeningeal metastasis.
Molecular biologist John Petrini of the Sloan Kettering Institute.
Feature
Scientists know that cancer can result from mistakes in DNA repair. But understanding what controls the repair process itself has been a hard nut to crack.
MSK researchers used the genome-editing tool CRISPR to create more potent chimeric antigen receptor (CAR) T cells that don't tire as easily when attacking cancer cells. The unexpected findings were published in the journal Nature on February 22 and underscore the potential of genome editing to advance immunotherapy for cancer.
CAR T cells attacking cancer
In the Lab
What do you get when you combine two of the hottest areas of biotechnology? A new paper from MSK researchers explains.
Medical illustration of nanoparticle spheres attacking cancer cell, which is beginning to disintegrate.
In the Lab
Researchers devised a novel method to ferry drugs to head and neck cancers using nanoparticles that naturally stick to a protein in tumor blood vessels.
Histology images of stem cells and AML cells
In the Lab
A new laboratory tool will allow researchers to study the progression from normal cells to myelodysplastic syndromes to an aggressive type of leukemia.
MSK scientists Charles Rudin and John Poirier
In the Lab
An epigenetic mechanism may make small cell lung cancer vulnerable to a new kind of attack.